Switch theme
Sign up to access all valuation multiples
Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle-to upper-income consumers. Clicks' business focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. It uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market. The company's reportable segments are; Retail, which generates maximum revenue, and Distribution.
1968
19.6K+
LTM Revenue $2.7B
LTM EBITDA $349M
$5.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clicks Group has a last 12-month revenue (LTM) of $2.7B and a last 12-month EBITDA of $349M.
In the most recent fiscal year, Clicks Group achieved revenue of $2.5B and an EBITDA of $333M.
Clicks Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Clicks Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | XXX | $2.5B | XXX | XXX | XXX |
| Gross Profit | $587M | XXX | $591M | XXX | XXX | XXX |
| Gross Margin | 22% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $349M | XXX | $333M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBIT | $255M | XXX | $233M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $174M | XXX | $158M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Clicks Group's stock price is ZAR 388 (or $22).
Clicks Group has current market cap of ZAR 92.0B (or $5.1B), and EV of ZAR 94.3B (or $5.2B).
See Clicks Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.2B | $5.1B | XXX | XXX | XXX | XXX | $0.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Clicks Group has market cap of $5.1B and EV of $5.2B.
Clicks Group's trades at 2.0x EV/Revenue multiple, and 15.3x EV/EBITDA.
Equity research analysts estimate Clicks Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clicks Group has a P/E ratio of 29.4x.
See valuation multiples for Clicks Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.1B | XXX | $5.1B | XXX | XXX | XXX |
| EV (current) | $5.2B | XXX | $5.2B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 15.1x | XXX | 15.3x | XXX | XXX | XXX |
| EV/EBIT | 20.6x | XXX | 21.6x | XXX | XXX | XXX |
| EV/Gross Profit | 8.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 29.4x | XXX | 31.0x | XXX | XXX | XXX |
| EV/FCF | 42.2x | XXX | 45.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClicks Group's last 12 month revenue growth is 9%
Clicks Group's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $18K for the same period.
Clicks Group's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clicks Group's rule of X is 35% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clicks Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 9% | XXX | XXX | XXX |
| Rule of 40 | 22% | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $18K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 14% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clicks Group acquired XXX companies to date.
Last acquisition by Clicks Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Clicks Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Clicks Group founded? | Clicks Group was founded in 1968. |
| Where is Clicks Group headquartered? | Clicks Group is headquartered in South Africa. |
| How many employees does Clicks Group have? | As of today, Clicks Group has 19.6K+ employees. |
| Who is the CEO of Clicks Group? | Clicks Group's CEO is Ms. Bertina Engelbrecht. |
| Is Clicks Group publicy listed? | Yes, Clicks Group is a public company listed on JSE. |
| What is the stock symbol of Clicks Group? | Clicks Group trades under CLS ticker. |
| When did Clicks Group go public? | Clicks Group went public in 1996. |
| Who are competitors of Clicks Group? | Similar companies to Clicks Group include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Clicks Group? | Clicks Group's current market cap is $5.1B |
| What is the current revenue of Clicks Group? | Clicks Group's last 12 months revenue is $2.7B. |
| What is the current revenue growth of Clicks Group? | Clicks Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Clicks Group? | Current revenue multiple of Clicks Group is 2.0x. |
| Is Clicks Group profitable? | Yes, Clicks Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Clicks Group? | Clicks Group's last 12 months EBITDA is $349M. |
| What is Clicks Group's EBITDA margin? | Clicks Group's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Clicks Group? | Current EBITDA multiple of Clicks Group is 15.1x. |
| What is the current FCF of Clicks Group? | Clicks Group's last 12 months FCF is $124M. |
| What is Clicks Group's FCF margin? | Clicks Group's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Clicks Group? | Current FCF multiple of Clicks Group is 42.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
